• 1. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 2. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 3. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300
• 4. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 5. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644

Research Briefing on 4-(Phenyl-D5)-3-buten-2-one (CAS: 56187-93-0) in Chemical and Biomedical Applications

4-(Phenyl-D5)-3-buten-2-one (CAS: 56187-93-0) is a deuterated analog of 4-phenyl-3-buten-2-one, a compound of significant interest in chemical and biomedical research due to its versatile applications in synthetic chemistry, drug development, and metabolic studies. The incorporation of deuterium (D5) at the phenyl ring enhances its utility as a stable isotope-labeled internal standard in mass spectrometry-based assays, improving the accuracy and precision of quantitative analyses in pharmacokinetic and metabolomic studies. Recent advancements in the synthesis and application of this compound have expanded its role in cutting-edge research.

Recent studies have focused on optimizing the synthetic pathways for 4-(Phenyl-D5)-3-buten-2-one to achieve higher yields and purity, which are critical for its use in high-sensitivity analytical techniques. A 2023 publication in the Journal of Labelled Compounds and Radiopharmaceuticals detailed a novel catalytic deuteration method that minimizes side reactions and maximizes isotopic purity. This method employs palladium-based catalysts under mild conditions, offering a scalable and cost-effective approach for industrial and academic laboratories.

In the biomedical field, 4-(Phenyl-D5)-3-buten-2-one has been employed as a key intermediate in the synthesis of deuterated drug candidates. Its stable isotope labeling allows for precise tracking of drug metabolites in vivo, facilitating the development of new therapeutic agents with improved metabolic stability and reduced toxicity. A recent study in the European Journal of Medicinal Chemistry highlighted its use in the synthesis of deuterated kinase inhibitors, which demonstrated enhanced pharmacokinetic profiles in preclinical models.

Furthermore, the compound's role in elucidating metabolic pathways has been underscored by its application in isotope dilution mass spectrometry (IDMS). Researchers have utilized 4-(Phenyl-D5)-3-buten-2-one to quantify endogenous metabolites in complex biological matrices, enabling breakthroughs in understanding disease mechanisms and biomarker discovery. A 2024 study published in Analytical Chemistry reported its successful use in profiling oxidative stress markers in neurodegenerative diseases, providing new insights into disease progression and potential therapeutic targets.

In conclusion, 4-(Phenyl-D5)-3-buten-2-one (CAS: 56187-93-0) continues to be a valuable tool in chemical and biomedical research, with its applications spanning synthetic chemistry, drug development, and metabolic studies. Ongoing research efforts are expected to further expand its utility, particularly in the development of next-generation deuterated pharmaceuticals and advanced analytical methodologies. Future directions may include exploring its potential in targeted drug delivery systems and as a probe for studying enzyme mechanisms.

• 1896-62-4(Benzylideneacetone)
• 307496-22-6(3-Buten-2-one-1,1,1,3,4-d5,4-(phenyl-d5)- (9CI))
• 538-58-9(1,5-Diphenylpenta-1,4-dien-3-one)
• 122-57-6(Benzylideneacetone)
• 622-21-9(Dicinnamalacetone)
• 130208-38-7(3-Buten-2-one-1,1,1,3-d4,4-phenyl- (9CI))
• 35225-79-7(trans-Dibenzylideneacetone)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)